Heartflow (HTFL) FCF Margin (2024 - 2025)
Heartflow (HTFL) posted FCF Margin of 25.43% for Q4 2025, down 180.75% on a QoQ basis from 9.06% in Q3 2025, and up 1565.0% year-over-year from 1.53% in Q4 2024.
Powered by 
Analysis
Heartflow (HTFL) FCF Margin (2024 - 2025) Analysis & Trends
Heartflow has reported FCF Margin for 2 years, with the latest figure at 25.43% in Q4 2025.
- On a quarterly basis, FCF Margin rose 1565.0% year-over-year to 25.43% in Q4 2025; TTM through Dec 2025 was 24.36%, a N/A change from a year earlier, with the FY2025 full-year figure at 33.54%, up 2477.0% from the prior year.
- FCF Margin was 25.43% for Q4 2025 at Heartflow, down from 9.06% in the prior quarter.
- The five-year high for FCF Margin was 9.06% in Q3 2025, with the low at 41.08% in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 1.28% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 23.15% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 11.63% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -52.87% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -45.84% |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 5.70% |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | -44.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -25.43% |
| Sep 30, 2025 | -9.06% |
| Dec 31, 2024 | -41.08% |
| Sep 30, 2024 | -34.27% |